We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Implantable Platform Continuously Monitors Tissue Oxygen

By HospiMedica International staff writers
Posted on 26 Oct 2016
Print article
Image: The Lumee Oxygen Platform, with the oxygen-sensitive biosensor (4) (Photo courtesy of Profusa).
Image: The Lumee Oxygen Platform, with the oxygen-sensitive biosensor (4) (Photo courtesy of Profusa).
A new system based on implanted biosensors allows the continuous and long-term monitoring of oxygen levels in subcutaneous tissues in the upper extremity, shoulder, or lower extremity.

The Lumee Oxygen Platform is an instrument adjunct to the treatment of peripheral artery disease (PAD), which is based on tiny, flexible biosensors 5 mm long and approximately 500 microns in diameter injected into subdermal tissue. Each biosensor is made of a bioengineered hydrogel fiber that forms a porous, tissue-integrating scaffold that induces capillary and cellular ingrowth from surrounding tissue. The smart gel is linked to a fluorescent molecule that signals the presence of oxygen.

The platform is comprised of the novel hydrogel biosensors, a specially designed biosensor injector, an optical reader, and a touch screen user interface. Either taped to the skin’s surface or held by hand, the optical reader transmits light through the skin to the embedded biosensor, which emits a corresponding fluorescence that is proportional to oxygen concentration. The data is relayed to the touch-screen tablet computer for an encrypted personal record and historical tracking.

The Lumee Oxygen Platform, a product of Profusa (San Francisco, CA, USA), has received the European Community CE mark of approval. According to the company, the smart hydrogel biosensors may have many other applications for consumer health and wellness, including management of other chronic diseases such as diabetes and chronic obstructive pulmonary disease (COPD), but should not be used as the sole basis for diagnosis or therapy.

“Acquiring the CE Mark is a major milestone our development team and regulatory partners have worked hard to achieve,” said Ben Hwang, PhD, chairman and CEO of Profusa. “Thanks to their dedication and commitment, vascular interventionalists in Europe can now have a revolutionary monitoring device that enables them to better treat their patients and improve their quality of life.”

“The muscles and other tissues of the arms and legs need oxygen and nutrients to function properly; in PAD the arteries that feed the extremity are blocked by plaque composed of cholesterol and other calcified substances,” said Miguel Montero, MD, associate professor of surgery at Baylor College of Medicine (Houston, TX, USA). “When low tissue oxygen is detected early, more treatment options can be considered and the need for catastrophic amputation can be avoided.”

Decreased tissue oxygen levels in the lower limbs of PAD patients can lead to disabled walking, or in more advanced cases, gangrene and subsequent amputation. By continuously measuring tissue oxygen levels in the ischemic limb before, during, and after treatment, appropriate therapy can be administered in a timely fashion before advanced symptoms appear.

Related Links:
Profusa
Baylor College of Medicine

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Endoscope Tracking Software
T-DOC Endo

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.